Hitoshi Nishizawa Selected Research

Autoimmune Hypophysitis

11/2019	Pathogenesis of Anti-PIT-1 Antibody Syndrome: PIT-1 Presentation by HLA Class I on Anterior Pituitary Cells.
1/2017	A novel thymoma-associated autoimmune disease: Anti-PIT-1 antibody syndrome.
10/2015	A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis.
2/2014	The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature.
1/2014	A missense single-nucleotide polymorphism in the sialic acid acetylesterase (SIAE) gene is associated with anti-PIT-1 antibody syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hitoshi Nishizawa Research Topics

Disease

17	Obesity 01/2022 - 04/2002
13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 06/2003
11	Insulin Resistance 01/2019 - 07/2002
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 06/2003
7	Acromegaly 12/2015 - 01/2008
6	Neoplasms (Cancer) 01/2022 - 03/2008
6	Non-alcoholic Fatty Liver Disease 01/2019 - 03/2007
6	Hypertension (High Blood Pressure) 01/2018 - 06/2003
6	Hypoadiponectinemia 01/2017 - 09/2002
6	Body Weight (Weight, Body) 05/2014 - 11/2003
5	Atherosclerosis 04/2022 - 09/2002
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 09/2002
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2007
5	Heart Failure 10/2020 - 09/2011
5	Autoimmune Hypophysitis 11/2019 - 01/2014
5	Inflammation (Inflammations) 11/2016 - 07/2012
4	Fibrosis (Cirrhosis) 01/2022 - 05/2008
4	Hypoxia (Hypoxemia) 01/2018 - 03/2008
4	Coronary Artery Disease (Coronary Atherosclerosis) 06/2006 - 04/2002
3	Hyperglycemia 01/2022 - 09/2003
3	Hypothyroidism 01/2017 - 01/2011
2	ST Elevation Myocardial Infarction 12/2022 - 08/2017
2	Hypertriglyceridemia 09/2022 - 11/2006
2	Neointima 01/2021 - 01/2017
2	Ischemia 01/2021 - 09/2013
2	Cardiomegaly (Heart Hypertrophy) 01/2020 - 02/2014
2	Glucose Intolerance 01/2019 - 01/2011
2	Malnutrition (Nutritional Deficiencies) 01/2018 - 09/2013
2	Dyslipidemias (Dyslipidemia) 01/2018 - 06/2003
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 12/2003
2	Cushing Syndrome 01/2017 - 01/2014
2	Hypertrophy 02/2014 - 03/2011
2	Vascular Diseases (Vascular Disease) 11/2003 - 04/2002
1	Pancreatitis 09/2022
1	Hyperuricemia 04/2022
1	Overnutrition 04/2022
1	Gout 04/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2022
1	Diabetes Mellitus 08/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Reperfusion Injury 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Gastritis 03/2020

Drug/Important Bio-Agent (IBA)

28	AdiponectinIBA 01/2022 - 07/2002
13	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 01/2008
12	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2002
11	Insulin (Novolin)FDA Link 05/2019 - 07/2002
11	Growth Hormone (Somatotropin)IBA 01/2017 - 03/2007
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2003
7	Messenger RNA (mRNA)IBA 02/2014 - 04/2002
5	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 03/2007
5	AdipokinesIBA 11/2009 - 04/2002
4	H-cadherin (T-cadherin)IBA 12/2022 - 01/2017
3	Triglycerides (Triacylglycerol)IBA 09/2022 - 03/2007
3	purineIBA 04/2022 - 09/2013
3	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2019 - 01/2014
3	ProlactinIBA 01/2017 - 01/2011
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2017 - 01/2011
2	MB Form Creatine KinaseIBA 12/2022 - 08/2017
2	Apolipoproteins E (ApoE)IBA 09/2022 - 01/2017
2	Xanthine DehydrogenaseIBA 04/2022 - 09/2013
2	Uric Acid (Urate)IBA 04/2022 - 09/2013
2	LigandsIBA 01/2022 - 03/2007
2	thiazole-4-carboxamide adenine dinucleotide (TCAD)IBA 01/2021 - 01/2017
2	EnzymesIBA 05/2019 - 01/2014
2	Hormones (Hormone)IBA 10/2018 - 10/2002
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 01/2016
2	Insulin-Like PeptidesIBA 01/2016 - 06/2012
2	Immunoglobulin G (IgG)IBA 10/2015 - 02/2014
2	Angiotensin IIIBA 02/2014 - 05/2008
2	Liraglutide FDA Link 01/2014 - 09/2012
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2014 - 09/2012
2	LipidsIBA 01/2014 - 03/2007
2	AntioxidantsIBA 03/2011 - 06/2010
2	PPAR alphaIBA 05/2008 - 03/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008 - 07/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2022
1	InflammasomesIBA 04/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Claudin-5IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	ChemokinesIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Transaminases (Aminotransferases)IBA 08/2021
1	FYX-051IBA 01/2021
1	AcidsIBA 03/2020
1	GastrinsIBA 03/2020
1	CollagenIBA 01/2020
1	DisintegrinsIBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	EpitopesIBA 11/2019

Therapy/Procedure

13	Therapeutics 04/2022 - 06/2006
4	Glycemic Control 08/2021 - 09/2012
2	Percutaneous Coronary Intervention 12/2022 - 08/2017
2	Bariatric Surgery 01/2022 - 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Kidney Transplantation 01/2021